Clemson Football

ACC Commissioner Jim Phillips, ACC Chairman, respond to FSU Board

The ACC released a statement just after Florida State's Board of Trustees decision to move forward with a challenge to the Grant of Rights agreement.
December 22, 2023
2.4k Views
Discuss
Story Poster
Photo by Jaylynn Nash/ ACC

Statement from ACC Commissioner Jim Phillips, Ph.D., and Jim Ryan, Chair of the ACC Board of Directors, on Florida State’s Board of Trustees Meeting

“Florida State’s decision to file action against the Conference is in direct conflict with their longstanding obligations and is a clear violation of their legal commitments to the other members of the Conference. All ACC members, including Florida State, willingly and knowingly re-signed the current Grant of Rights in 2016, which is wholly enforceable and binding through 2036. Each university has benefited from this agreement, receiving millions of dollars in revenue and neither Florida State nor any other institution, has ever challenged its legitimacy. 

“As a league, we are proud of the successes of our student-athletes and that the ACC has won the most NCAA National Championships over the past two and half years while also achieving the highest graduation success and academic performance rates among all FBS conferences, so it is especially disappointing that FSU would choose to pursue this unprecedented and overreaching approach.

“We are confident that the Grant of Rights, which has been honored by all other universities who signed similar agreements, will be affirmed by the courts and the Conference’s legal counsel will vigorously enforce the agreement in the best interests of the ACC’s current and incoming members.” 

Discuss
Discussion from...

ACC Commissioner Jim Phillips, ACC Chairman, respond to FSU Board

2,406 Views | 0 Replies | Last: 1 yr ago by Staff Reports
There are not any replies to this post yet.
Refresh
Page 1 of 1
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.